still here and still following my deeply impaired investment. Some many great lessons. The endless excuses, the dubious juristictions, the curiously low win rates at Aristo and on and on and on.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
